{"id":"antiemetic-combinations","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL1439973","moleculeType":"Small molecule","molecularWeight":"177.46"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This combination works by targeting multiple pathways involved in the regulation of nausea and vomiting, providing a more comprehensive approach to managing these symptoms.","oneSentence":"Combination of antiemetic drugs to prevent nausea and vomiting.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:10:35.792Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of nausea and vomiting associated with chemotherapy"}]},"trialDetails":[{"nctId":"NCT06279130","phase":"PHASE2, PHASE3","title":"Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations","status":"RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2024-01-29","conditions":"Resectable MMR-deficient Solid Tumors, Resectable MMR-proficient Solid Tumors","enrollment":133},{"nctId":"NCT04785911","phase":"","title":"Use of the Modified PUQE Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment","status":"COMPLETED","sponsor":"Tasnem Abo-elouon","startDate":"2021-09-05","conditions":"Hyperemesis Gravidarum","enrollment":200},{"nctId":"NCT03370328","phase":"NA","title":"Reducing Up-set Stomach and Vomiting After Surgery Using Essential Oils","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2018-03-12","conditions":"Nausea","enrollment":143},{"nctId":"NCT01543945","phase":"PHASE2","title":"Prevention Post Operative Nausea Vomiting in Ambulatory Gynecologic Laparoscopy","status":"COMPLETED","sponsor":"Prince of Songkla University","startDate":"2008-03","conditions":"Postoperative Nausea and Vomiting","enrollment":340},{"nctId":"NCT00147355","phase":"PHASE3","title":"Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 Substudy","status":"TERMINATED","sponsor":"Kirby Institute","startDate":"2005-11","conditions":"HIV Infections","enrollment":28},{"nctId":"NCT00791960","phase":"NA","title":"Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2008-11","conditions":"Nausea, Vomiting","enrollment":149}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":23,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Steroids","Anti histamine"],"phase":"phase_2","status":"active","brandName":"Antiemetic Combinations","genericName":"Antiemetic Combinations","companyName":"Tasnem Abo-elouon","companyId":"tasnem-abo-elouon","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Combination of antiemetic drugs to prevent nausea and vomiting. Used for Prevention of nausea and vomiting associated with chemotherapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}